ASX:EXL Elixinol Wellness (EXL) Stock Price, News & Analysis → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free EXL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Elixinol Wellness alerts: Email Address Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… About Elixinol WellnessElixinol Wellness Limited, through its subsidiaries, manufactures and distributes hemp derived nutraceuticals, cosmetics, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. Elixinol Wellness Limited was incorporated in 2017 and is headquartered in Sydney, Australia.Read More Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… EXL Stock News HeadlinesOctober 30, 2023 | msn.comRise and Shine: Everything you need to know before the ASX openSeptember 4, 2023 | finance.yahoo.comElixinol Wellness First Half 2023 Earnings: AU$0.009 loss per share (vs AU$0.023 loss in 1H 2022)April 23, 2024 | Stansberry Research (Ad)The "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. November 29, 2022 | proactiveinvestors.com.auFIVE at FIVE AU: House prices set for 2024 revival; is lithium set for a fall?August 13, 2022 | au.finance.yahoo.comElixinol Wellness Limited (EXL.AX)December 20, 2021 | proactiveinvestors.com.auElixinol Wellness inks licence agreement with UK's leading cannabis producerAugust 11, 2021 | barrons.comElixinol Wellness Ltd.See More Headlines Receive EXL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Elixinol Wellness and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolASX:EXL CUSIPN/A CIKN/A Webwww.elixinolglobal.com Phone61 2 4044 4585FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,510,000.00 Net Margins-90.79% Pretax MarginN/A Return on Equity-96.12% Return on Assets-29.99% Debt Debt-to-Equity Ratio19.53 Current Ratio1.64 Quick Ratio2.80 Sales & Book Value Annual Sales$8.27 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares1,270,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta2.12 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Ronald Dufficy BECFCPA, Group CEO, MD & DirectorMs. Josephine LorenzGlobal CFO & Joint Company SecretaryGlen ZurcherAccount Director of Investor Relations DepartmentMs. Sarah Prince ACISBA, GrdDipCorpGov, LLB, Joint Company SecretaryKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All CompetitorsInsidersRon DufficySold 3,171,994 sharesTotal: $15,859.97 ($0.01/share)Ron DufficySold 548,077 sharesTotal: $5,480.77 ($0.01/share)Ron DufficyBought 902,778 shares on 11/23/2023Total: $12,638.89 ($0.01/share)Ron DufficySold 902,778 sharesTotal: $9,027.78 ($0.01/share)Helen WisemanSold 555,556 sharesTotal: $7,777.78 ($0.01/share) This page (ASX:EXL) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elixinol Wellness Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
